Session » Abstracts: Pediatric Rheumatology – Clinical I
- 1:00PM-2:30PM
-
Abstract Number: 2569
A Novel Hyperferritinemia Screen to Aid Differentiation of Hyperinflammatory Disorders
- 1:00PM-2:30PM
-
Abstract Number: 2572
Biomarker-guided Treatment-and-stop-strategy for Recombinant IL-1Receptor Antagonist (Anakinra) in Patients with Systemic Juvenile Idiopathic Arthritis
- 1:00PM-2:30PM
-
Abstract Number: 2570
Comparison of the Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Juvenile Idiopathic Arthritis- Associated Lung Disease (SJIA-LD) Cohort to CARRA Registry SJIA Patients Without Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 2573
Efficacy and Safety of Ixekizumab in Children with Active Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis (COSPIRIT-JIA): 16-week Results of a Multicentre, Randomised, Open-label Study
- 1:00PM-2:30PM
-
Abstract Number: 2574
Tear Biomarkers for Monitoring Disease Activity and Progression of Noninfectious Chronic Anterior Uveitis in Children
- 1:00PM-2:30PM
-
Abstract Number: 2571
Trajectories of Physical Function in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry